Zio® by iRhythm Shown to Prevent Hospital Admissions, Aid in Early Detection of AF

Zio The new clinical evidence further validates the Zio service as a viable solution for the early detection of atrial fibrillation (AF),1 helping undiagnosed populations effectively seek treatment before more serious problems can occur.

← Previous
Next →
  • Medical Specialists Subscribe
  • Industry Subscribe
  • Privacy Statement
    • Cookie Policy
  • Contact
  • Medical Specialists Subscribe
  • Industry Subscribe
  • Privacy Statement
    • Cookie Policy
  • Contact
  • ADVERTISE
  • ADVERTISE

© 2026 All rights Reserved. Medical Device News Magazine, a Division of PTM Healthcare Marketing, Inc.